A selective sphingosine kinase 1 inhibitor integrates multiple molecular therapeutic targets in human leukemia
Steven W. Paugh, Sarah Spiegel(Georgetown University Medical Center)
Cited by 247
Related Papers
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2014|1.4k
Sphingolipid metabolites in inflammatory disease
|Nature|2014|1.3k
Novel mutations target distinct subgroups of medulloblastoma
|Nature|2012|853
SphK1 and SphK2, Sphingosine Kinase Isoenzymes with Opposing Functions in Sphingolipid Metabolism
|Journal of Biological Chemistry|2005|630
Sphingosine 1-Phosphate, a Key Cell Signaling Molecule
|Journal of Biological Chemistry|2002|558